Lunch & Learn

New Drugs and Biologics Lunch & Learn

Seating for this session is limited and will be allocated on a first-come, first-served basis. Stay ahead of the curve with this informative Lunch & Learn session, where we’ll explore the latest developments in pharmaceuticals and biologics expected to shape the treatment landscape in the near future. This session will highlight the potential clinical applications, safety profiles, and cost considerations of these new treatments, equipping them with the knowledge needed to anticipate future changes in medication management.
Seating for this session is limited and will be allocated on a first-come, first-served basis. Stay ahead of the curve with this informative Lunch & Learn session, where we’ll explore the latest developments in pharmaceuticals and biologics expected to shape the treatment landscape in the near future. This session will highlight the potential clinical applications, safety profiles, and cost considerations of these new treatments, equipping them with the knowledge needed to anticipate future changes in medication management.

Learning Objectives

  • Identify newly approved and emerging drugs and biologics from the 2024 calendar year and their potential clinical applications.
  • Describe the mechanisms of action and unique attributes of these novel therapies.
  • Discuss safety, efficacy, and economic considerations associated with new treatments.
  • Speaker(s)

    Speaker
    Speaker
    Speaker
    Speaker
    Speaker
    Speaker
    Speaker
    Speaker
    Speaker
    Speaker

    Share: